Biological Behavior of Papillary Carcinoma of the Thyroid Including Squamous Cell Carcinoma Components and Prognosis of Patients Who Underwent Locally Curative Surgery
Table 2
Intraoperative and pathological findings and prognosis of 10 patients with PTC-SCC.
Patient no.
Surgical designs
Resection
Extrathyroid extension
Pathology (primary)
Pathology (LN meta)
Adjuvant therapies
Carcinoma recurrence
Outcome after diagnosis
1
TT + MND
R0?
Yes
**PTC > SCC (10%)
PTC
*chemo
Bone
18 m DOC
2
CT + MND
R0
x
x
PTC > SCC (<10%)
x
x
43 m ANEC
3
MND
R0
x
x
PTC > SCC (40%) > UC
Chemo
x
33 m AWC
4
TT + CND
R0
Yes
SCC (40%) > UC > PTC
PTC
*chemo
, Bone
23 m DOC
5
TT + MND
R0
Yes
SCC (80%) > PTC (tall)
PTC
Chemo + EBRT
Skin, local
18 m ANEC
6
TT + MND
R0?
Yes
PTC > SCC (<10%)
PTC
x
x
14 m ANEC
7
TT + MND
R0
Yes
PTC (tall) > SCC (40%)
PTC
EBRT
x
13 m ANEC
8
LI + MND
R0
Yes
PTC (tall) > SCC (10%)
PTC
*chemo + EBRT
x
9 m ANEC
9
TT + MND
R0
Yes
PTC (tall) > SCC (20%)
PTC
Immunotherapy
Lung
9 m DOC
10
TT + MMD
R1
Yes
PTC > SCC (20%)
PTC
Chemo for lung carcinoma
x
5 m ANEC
*Preoperative chemotherapy was also performed. of UC. **A > B indicates A occupied a larger portion than B. TT: total thyroidectomy, CT: completion total thyroidectomy, LI: lobectomy with is thymectomy, CND: central node dissection, MND: modified radical neck dissection, EBRT; external beam radiotherapy. DOC; Died of carcinoma. ANEC: Alive with no evidence of Carcinoma. AWC: Alive with carcinoma.